Morning Brief, Tuesday 4 August

Spain and Morocco moved fast after tens of thousands of people crossed into Ceuta by land and sea, but the political damage travelled faster than the return buses. Estimates put the arrivals between 50,000 and 60,000, while reported death tolls ranged from 83 to 88 after people drowned or were crushed near the Tarajal breakwater. Spain said most entrants had returned to Morocco by 3 August, though several thousand remained in the enclave and hundreds of minors entered the care system in Ceuta and Melilla.

Madrid praised Rabat's cooperation and blamed online disinformation for helping trigger the surge. Italy suspended Schengen arrangements with Spain, a mostly symbolic move given geography, and Denmark and other northern countries backed a harder line. Spain called that theatre and accused Rome of failing on migration; Antonio Tajani replied with falling Italian arrival figures and a pointed shrug.

European Commission President Ursula von der Leyen tried to turn the quarrel into a programme: more cooperation with third countries, stronger external borders, warning systems, action against smugglers and faster returns. She also warned that migration could not become a pressure tool against member states.

The hard question now is not whether Europe wants control, since every capital says it does, but whether it can build shared control before the next crowd reaches a fence or a beach.

Donald Trump told reporters that talks with Iran were happening “right now” and cast the moment as Tehran's final opening for a deal. Iran's foreign ministry said the opposite, insisting it was not negotiating with Washington and was only discussing a temporary safe maritime route with Oman. The dispute matters because the Strait of Hormuz, which carried about a fifth of traded oil and gas before the war, has seized up during the five-month conflict.

Donald Trump framed the talks as an ultimatum.

Markets chose to hear the word “talks” rather than the denial. Brent crude fell more than 5% in early trading and later more than 6%, travel shares rose, energy stocks slipped and Gulf bourses gained. The reaction showed how starved investors are for any sign that Hormuz may reopen and oil supply may normalise.

The same day brought a reminder of how wide the conflict's legal and human shadow has spread. Iran hanged Omid Behzad and Pouria Safvat after convicting them of passing coordinates and photographs of military and security sites to Mossad, while rights groups attacked the proceedings as closed and coerced. Diplomacy built on contradictory press lines can move markets for a day; it cannot by itself reopen a strait, empty prisons or stop the next escalation.

The Gaza ceasefire roadmap narrowed to one question: who moves first. Donald Trump's Board of Peace said Israel's full withdrawal beyond the Yellow Line would happen only after Hamas completed decommissioning of light weapons, heavy weapons and tunnels. Israel welcomed that sequence, while Hamas has tied the handover of heavy weapons to Israeli withdrawal and a political horizon for Palestinians. Sunday's Israeli strikes killed 18 people across Gaza, according to the Hamas-run civil defence service, while the Israeli military said it targeted military operatives (1191cf5a-4285-ab05-f24a539e2b3f).

Doron Spielman, Benjamin Netanyahu's spokesman, put Israel's condition bluntly.

The war in Ukraine produced its own civilian shock on Russia's Black Sea coast. A drone crashed into a crowded beach at Arkhipo-Osipovka near Gelendzhik, killing seven people, including three children, and injuring about 40. Russian officials called it a deliberate strike on civilians; Ukrainian channels suggested the drone may have been disabled by electronic warfare or may have missed a defence-linked facility near the beach. Kyiv made no public comment, and eyewitness reports of gunfire before the explosion supported, but did not prove, an interception scenario.

Both incidents show how modern wars turn sequencing, targeting and technical failure into public verdicts before investigators can catch up. Civilians are becoming the audit trail of conflicts whose official explanations rarely arrive uncontested.

Germany's Rhine is approaching a measurement that sounds too small for Europe's busiest inland waterway. Officials forecast the Kaub gauge, the key chokepoint between Mainz and Koblenz, at just 18 cm by Friday, below the 2018 record of 25 cm. Cargo vessels can now carry only about 20% of full load, pushing up freight rates for coal, oil products, grain, minerals and ores, and economists warned the disruption could trim German third-quarter growth by 0.1 to 0.2 percentage points.

Romania went further than convening a meeting. Its naval forces detonated 180 kg of explosives in the Danube's Bala canal to redirect water towards the Cernavodă nuclear plant, where one reactor had already shut and the remaining reactor was running at reduced capacity. Hungary's Paks plant also cut output sharply as the Danube carried only a fraction of its normal seasonal volume, forcing governments to ask households and industry to save power.

Heat added a public-health and fire dimension. Italy placed 25 of 27 monitored cities under maximum heat alert as temperatures held near or above 40°C and the Po at Cremona hit a historic low. Greece sent more than 400 firefighters and 21 aircraft against a wildfire northwest of Athens, where five fire-related deaths and repeated evacuations have turned another summer blaze into a national test.

The climate bill is arriving not as a single invoice, but as freight delays, power alerts, hospital pressure and ash on doorsteps.

AstraZeneca's reported preliminary merger talks with Bristol Myers Squibb received the market equivalent of a raised eyebrow and a slammed door. Shares fell roughly 7% in London after earlier dropping as much as 8.8%, wiping nearly £15 billion from the company's value. Investors questioned why Pascal Soriot would buy a US rival facing a steep patent cliff when AstraZeneca already targets $80 billion in revenue by 2030 and has a strong pipeline in cancer, obesity and respiratory disease.

Markus Manns, a shareholder in both companies, captured the mood.

The political risks look awkward too. A combined company would rank among the world's biggest drugmakers and face antitrust scrutiny in oncology and cardiovascular medicines. London would also worry that a deal with a US rival could increase pressure for AstraZeneca to shift its main listing to New York, a nasty prospect for a stock exchange already short of trophies.

Boeing received a cleaner kind of corporate news. The FAA certified the 737 MAX 7 after nearly a decade of review, 441 flight tests and 686 flight-test hours, clearing a path for deliveries to Southwest Airlines in 2027. Yet the approval still sits in the long shadow of the MAX crashes, the 2024 Alaska Airlines panel incident and continuing FAA factory oversight.

For AstraZeneca, ambition now looks like a risk; for Boeing, permission still comes with a chaperone.